Asset Management Resources’s Regeneron Pharmaceuticals REGN Stock Holding History

Asset Management Resources’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$393K	Sell	448 -109	-20%	-$89.8K	0.22%	33
2023 Q3	$458K	Sell	557 -15	-3%	-$11.8K	0.28%	29
2023 Q2	$411K	Sell	572 -140	-20%	-$108K	0.25%	31
2023 Q1	$585K	Sell	712 -162	-19%	-$122K	0.37%	21
2022 Q4	$631K	Sell	874 -15	-2%	-$11.1K	0.43%	23
2022 Q3	$612K	Buy	889 +29	+3%	+$18.3K	0.6%	21
2022 Q2	$508K	Sell	860 -94	-10%	-$61.1K	0.43%	22
2022 Q1	$666K	Sell	954 -14	-1%	-$8.86K	0.54%	20
2021 Q4	$611K	Buy	+968	New	+$595K	0.53%	20

Other funds holding REGN

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return